publicações selecionadas
-
artigo académico
- Optimization of Rifapentine-Loaded Lipid Nanoparticles Using a Quality-by-Design Strategy. Pharmaceutics. 2020
- Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model. Analytical Chemistry. 2019
- Antibiotic interactions using liposomes as model lipid membranes. Chemistry and Physics of Lipids. 2019
- Effect of the alkyl group in the piperazine N-substitution on the therapeutic action of rifamycins: A drug-membrane interaction study. Chemico-Biological Interactions. 2018
- Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment 2017
- The formulation of nanomedicines for treating tuberculosis. Advanced Drug Delivery Reviews. 2016
- Interactions of sulindac and its metabolites with phospholipid membranes: An explanation for the peroxidation protective effect of the bioactive metabolite. Free Radical Research. 2008
-
artigo de revista
- Sodium alginate/polycaprolactone co-axial wet-spun microfibers modified with N-carboxymethyl chitosan and the peptide AAPV for Staphylococcus aureus and human neutrophil elastase inhibition in potential chronic wound scenarios. Biomaterials Advances. 2023
- Antibacterial and hemostatic capacities of cellulose nanocrystalline-reinforced poly(vinyl alcohol) electrospun mats doped with Tiger 17 and pexiganan peptides for prospective wound healing applications. Biomaterials Advances. 2022
- Tiger 17 and pexiganan as antimicrobial and hemostatic boosters of cellulose acetate-containing poly(vinyl alcohol) electrospun mats for potential wound care purposes. International Journal of Biological Macromolecules. 2022
- Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials. 2021
- A selective p53 activator and anticancer agent to improve colorectal cancer therapy. Cell Reports. 2021
- Yicathins B and C and Analogues: Total Synthesis, Lipophilicity and Biological Activities. Chemmedchem. 2020
-
capítulo de livro
- New Approaches from Nanomedicine and Pulmonary Drug Delivery for the Treatment of Tuberculosis 2018
- Oral Administration of Nanoparticles-Based TB Drugs 2017
- Drug-Membrane Interactions: Molecular Mechanisms Underlying Therapeutic and Toxic Effects of Drugs 2010
- Use of Liposomes to Evaluate the Role of Membrane Interactions on Antioxidant Activity 2010
-
documento
- Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model 2020
- Optimization of lipid nanoparticles for tuberculosis therapy based on a quality-by-design strategy 2020
- Targeted delivery of rifampicin-loaded lipid nanoparticles for tuberculosis treatment 2020
- Biocompatibility and macrophage-targeting of mannosylated lipid nanoparticles for tuberculosis treatment 2019
- Nanostructured lipid carriers as a versatil oral delivery vehicle of rifampicin 2018
- Nanostructured lipid carriers as a versatile oral delivery vehicle of streptomycin 2018
- Nanostructured lipid carriers (NLCs) as a promising drug delivery system for streptomycin delivery 2018
- Rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment: an active targeting approach 2017
- Development of bacterial cellulose wound dressings with controlled delivery of vitamin D3 2017
- Development of innovative lipid nanoparticles for the treatment of tuberculosis 2017
- Nanostructured lipid carriers loaded as a promising drug delivery system for streptomycin 2017
- Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis 2016
- Nanostructured lipid carriers as drug delivery systems of rifapentine: a tool to overcome the drawbacks of tuberculosis oral therapy 2016
- Solid lipid nanoparticles for specific delivery of rifampicin to alveolar macrophages 2016
- Targeted nanostructured lipid carriers based epigallocatechin delivery system to cancer cells 2016